Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) – Global Forecast to 2030)”, is projected to reach USD 7.56 billion by 2030 from an estimated USD 3.81 billion in 2025, at a CAGR of 14.7% from 2025 to 2030. Several factors are contributing to the growth of this global market, including technological advancements, increased funding and investments in research and development, progress in stem cell research, a rising number of cancer cases, and an increasing emphasis on personalized medicine. Additionally, the growing adoption of single-cell sequencing and the integration of microfluidic techniques with cell analysis are expected to further support market growth. However, the high cost of single-cell analysis products may hinder this growth. Furthermore, technical challenges and ethical considerations related to single-cell analysis could pose additional obstacles to market expansion.
The consumables segment accounted for the largest share of the single-cell analysis products market in 2024.
Based on products, the single-cell analysis market is segmented into consumables and instruments. The consumables segment is further divided into reagents, assay kits, beads, microplates, and other consumables. Theinstruments segment is further segmented into next-generation sequencing, microscopy, flow cytometry, polymerase chain reaction, mass spectrometry, and other instruments. The consumables segment dominated the market in 2024 and is expected to continue to dominate the market during the forecast period. The large share of this segment can be attributed to the increasing demand for high-quality reagents to ensure reliable and reproducible results. Additionally, the growing focus on the development of advanced cellular therapies is anticipated to promote segmental growth.
The academic & research laboratories segment is estimated to register the highest growth rate during the forecast period in the single-cell analysis market.
Based on end users, the single-cell analysis market is segmented into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and cell banks & IVF centers. The academic & research laboratories segment is estimated to register the highest growth rate during the forecast period. The increasing emphasis on developing cell-based therapeutics, driven by the rising incidence of cancer, is anticipated to propel growth in this segment. Moreover, the surge in investments and funding for life science research has led to a greater adoption of advanced technologies, such as single-cell analysis, further enhancing the segment’s growth in the market.
The Asia Pacific region is expected to register the highest CAGR during the forecast period of 2025–2030.
Based on region, the single-cell analysis market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific is anticipated to register the highest growth in the single-cell analysis market owing to the increasing focus on the development of cell-based therapies, high government investments & funding for R&D, and the booming healthcare sector. In addition, the emphasis on modernizing healthcare infrastructure and the increasing adoption of advanced technologies for research and clinical applications are expected to drive the growth of single-cell analysis in the Asia Pacific region.
The key players in the single-cell analysis market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), BD (US), Agilent Technologies, Inc. (US), QIAGEN (Netherlands), 10x Genomics (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), DiaSorin S.p.A. (Italy), Standard BioTools (US), Tecan Trading AG (Switzerland), Sartorius AG (Germany), Corning Incorporated (US), Cytek Biosciences (US), Takara Bio Inc. (Japan), bioMérieux (France), Revvity (US), Bio-Techne (US), PacBio (US), Bruker (US), Promega Corporation (US), Oxford Nanopore Technologies Plc (UK), The Menarini Group (Italy), Singleron Biotechnologies (Germany), BICO (Sweden), Fluent BioSciences (US), RareCyte, Inc. (US), Cell Microsystems (US), NanoCellect Biomedical (US), Apogee Flow Systems Ltd. (UK), Creative Biolabs (US), Sphere Bio (UK), and Yokogawa Electric Corporation (Japan), among others.